Idiotype-specific intravenous immunoglobulin for therapy of immunoglobulin kappa free light chain deficiency

Idiotype-specific intravenous immunoglobulin for therapy of immunoglobulin kappa free light chain deficiency

Deficient antibody production in patients with common variable immunodeficiency (CVID) is accompanied by an inability to produce free light chains (FLCs), particularly kappa (κ) FLC, due to B-cell dysfunction. We found that intravenous immunoglobulin (IVIg) administration, in a patient with CVID and...

Descrizione completa

Dettagli Bibliografici
Autori principali: Adina Elena Stanciu, Monica Popescu, Dan Cristian Gheorghe
Natura: Articolo
Lingua:English
Pubblicazione: Taylor & Francis Group 2019-05-01
Serie:Human Vaccines & Immunotherapeutics
Soggetti:
intravenous immunoglobulin
vaccine
kappa free light chain deficiency
common variable immunodeficiency
Accesso online:http://dx.doi.org/10.1080/21645515.2019.1572411

Accesso online

http://dx.doi.org/10.1080/21645515.2019.1572411

Documenti analoghi